Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (41-50 of 227) with videos related to

Pageof 23
Sort By:
The Journal of Investigative Dermatology|October 15, 2018
Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell TransplantationPeggy A Wu, Robert S Stern, Victor Huang, et al.
Clinical Hematology International|October 1, 2021
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell TransplantationZachariah DeFilipp, Nalu Navarro-Alvarez, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMohamed L Sorror, Brent R Logan, Xiaochun Zhu, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Secondary Esophageal Cancer After Hematopoietic Stem Cell Transplant: An Institutional Case SeriesAnupama Singh, Miles McAllister, Ashley L Deeb, et al.
Blood|March 3, 2012
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network studyJohn E Levine, Brent R Logan, Juan Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Blood Advances|May 26, 2022
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host diseaseHaesook T Kim, John Koreth, Jennifer Whangbo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive diseasePaul G Richardson, Vincent T Ho, Sergio Giralt, et al.
Haematologica|June 20, 2015
Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantationNatasha Kekre, Haesook T Kim, Gita Thanarajasingam, et al.
Pageof 23

Showing results (41-50 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Investigative Dermatology|October 15, 2018
Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell TransplantationPeggy A Wu, Robert S Stern, Victor Huang, et al.
Clinical Hematology International|October 1, 2021
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell TransplantationZachariah DeFilipp, Nalu Navarro-Alvarez, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMohamed L Sorror, Brent R Logan, Xiaochun Zhu, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Secondary Esophageal Cancer After Hematopoietic Stem Cell Transplant: An Institutional Case SeriesAnupama Singh, Miles McAllister, Ashley L Deeb, et al.
Blood|March 3, 2012
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network studyJohn E Levine, Brent R Logan, Juan Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Blood Advances|May 26, 2022
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host diseaseHaesook T Kim, John Koreth, Jennifer Whangbo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Therapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive diseasePaul G Richardson, Vincent T Ho, Sergio Giralt, et al.
Haematologica|June 20, 2015
Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantationNatasha Kekre, Haesook T Kim, Gita Thanarajasingam, et al.
Pageof 23